JENNIFER POTTER: Open Payments
NPI 1437190543 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,276 in 108 payments from 35 companies in 2025. Trend: 2023 $1,016 · 2024 $3,607 · 2025 $2,276
Food & beverage: $2,177Education: $99
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $330 |
| PFIZER INC. | 9 | $192 |
| Janssen Biotech, Inc. | 10 | $189 |
| Astellas Pharma US Inc | 4 | $150 |
| Gilead Sciences, Inc. | 9 | $141 |
| Daiichi Sankyo Inc. | 5 | $118 |
| Merck Sharp & Dohme LLC | 5 | $83 |
| Dendreon Pharmaceuticals LLC | 3 | $81 |
| ARRAY BIOPHARMA INC | 5 | $77 |
| GlaxoSmithKline, LLC. | 3 | $68 |
Products named: Trodelvy, KISQALI, Enhertu, KEYTRUDA, PROVENGE, SCEMBLIX, OJJAARA, RYBREVANT.
Industry payments across TX — which companies pay providers there.
